Avinger Inc AVGR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AVGR is a good fit for your portfolio.
News
-
Avinger Reports Fourth Quarter and Full Year 2023 Results
-
Avinger to Announce Full Year 2023 Results on March 20, 2024
-
Thinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys?
-
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
-
Thinking about buying stock in Avinger, Cloudflare, Backblaze, Shattuck Labs, or Beamr Imaging?
Trading Information
- Previous Close Price
- $3.93
- Day Range
- $3.64–4.01
- 52-Week Range
- $2.50–18.00
- Bid/Ask
- $3.72 / $3.85
- Market Cap
- $6.00 Mil
- Volume/Avg
- 73 / 59,367
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.39
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 76
- Website
- https://avinger.com
Valuation
|
Metric
|
AVGR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.39 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AVGR
|
|---|---|
Quick Ratio | 0.33 |
Current Ratio | 0.63 |
Interest Coverage | −9.66 |
Quick Ratio
AVGR
Profitability
|
Metric
|
AVGR
|
|---|---|
Return on Assets (Normalized) | −92.93% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −113.26% |
Return on Assets
AVGR
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Lhbsbhtsg | Wgsz | $130.9 Bil | |
BDX
| Becton Dickinson & Co | Fzvxvdmm | Xnnrbc | $67.6 Bil | |
ALC
| Alcon Inc | Stzrhqtd | Vyvnq | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Zzfvktydl | Pkzd | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Ttpxsvgxj | Phpsh | $27.5 Bil | |
RMD
| ResMed Inc | Fcvyxfbm | Zmlyjq | $26.5 Bil | |
BAX
| Baxter International Inc | Ytnprmzwt | Gvfkr | $20.6 Bil | |
COO
| The Cooper Companies Inc | Bqlnxvhhj | Ghnbr | $17.9 Bil | |
HOLX
| Hologic Inc | Ylnvjdpj | Wwdrxj | $17.9 Bil | |
TFX
| Teleflex Inc | Lnrl | Wwcm | $9.8 Bil |